Atlas Trials

A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer

Clinical trial NCT00183807 · TERMINATED

Trial details

NCT number
NCT00183807
Sponsor
University of Southern California
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2003-10-01
Primary completion
2006-02-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.